Histamine Antagonists
-
Subject Areas on Research
- Plasmodium chaperonin TRiC/CCT identified as a target of the antihistamine clemastine using parallel chemoproteomic strategy.
- A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy.
- A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection.
- A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease.
- An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
- Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine.
- Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.
- Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task.
- New Developments in Insomnia Medications of Relevance to Mental Health Disorders.
- Parental misinterpretations of over-the-counter pediatric cough and cold medication labels.
- Prescribing patterns of primary care physicians and otolaryngologists in the management of laryngeal disorders.
- Prescription Treatment Options.
- Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
- Utility of routine laboratory testing in management of chronic urticaria/angioedema.